Edick Paul R
SEC CIK 1531178 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks, Dir | 3.79M | $654.4K | — | 10 | 2021-10-05 | 2024-01-31 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
Edick Paul R made no open-market trades at XERS in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-31 | 2024-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | A - Grant | $0.00 | +1.50M | 3.79M | +66% | $0 |
| 2023-08-09 | 2023-08-09 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | P - Purchase | $2.38 | +10.0K | 2.29M | +0.4% | +$23.8K | |
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | A - Grant | $0.00 | +750.0K | 2.28M | +49% | $0 | |
| 2022-12-14 | 2022-12-13 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | P - Purchase | $1.45 | +20.0K | 1.53M | +1% | +$29.0K | |
| 2022-05-13 | 2022-05-12 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | P - Purchase | $1.40 | +100.0K | 1.51M | +7% | +$140.0K | |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | A - Grant | $0.00 | +600.0K | 1.41M | +74% | $0 | |
| I | 2021-11-16 | 2021-11-15 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | P - Purchase | $2.28 | +20.0K | 33.4K | +149% | +$45.6K |
| 2021-11-12 | 2021-11-11 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | P - Purchase | $2.08 | +200.0K | 808.1K | +33% | +$416.0K | |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | A - Grant | — | +608.1K | 608.1K | New | — |
| DI | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks, Dir | A - Grant | — | +13.4K | 13.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations